NCT03326063
- Conditions
- Aspirin-Sensitive Asthma With Nasal Polyps, Aspirin-exacerbated Respiratory Disease, Asthma, +16 more
- Locations
-
- Asthma Research Center, Brigham and Women's Hospital Boston, Massachusetts, United States
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,736 public trials
631 recruiting studies
Hypersensitivity, Immediate trial results
NCT03636919
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- Assistance Publique Des Hopitaux de Marseille Marseille, PACA, France
NCT05311475
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Sandoz Investigative Site Burgas, Bulgaria
- Sandoz Investigative Site Gabrovo, Bulgaria
- Sandoz Investigative Site Plovdiv, Bulgaria
- Sandoz Investigative Site Sliven, Bulgaria
NCT05937061
- Conditions
- Food Allergy, Food Hypersensitivity, Hypersensitivity, +2 more
- Locations
-
- Universitiy Medical center Ljubljana, division for Pediatrics Ljubljana, Slovenia
NCT04541004
- Conditions
- Allergic Rhinitis, Allergic Rhinoconjunctivitis, Hypersensitivity, +8 more
- Locations
-
- Alergologicka ambulance Čáslav, Czechia
- Alergopraktik s.r.o. Jablonec nad Nisou, Czechia
- Allergology Jihlava Jihlava, Czechia
- Oblastni nemocnice Kolin, a.s. Detske oddeleni. Alergologicka a Kolín, Czechia
Completed
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
NCT03531957
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Pinnacle Research Group, LLC Anniston, Alabama, United States
- Total Skin and Dermatology Center, PC. Birmingham, Alabama, United States
- Center for Dermatology Clinical Research, Inc. Fremont, California, United States
- L.A. Universal Research Center, Inc. Los Angeles, California, United States
NCT03074734
- Conditions
- Asthma, Bronchial Diseases, COPD, +13 more
- Locations
-
Not specified
NCT04656418
- Conditions
- Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
- Locations
-
- Clinical Research Center of Alabama Birmingham, Alabama, United States
- Medical Research of Arizona Scottsdale, Arizona, United States
- Raffi Tachdjian MD, Inc. Santa Monica, California, United States
- Allergy and Asthma Clinical Research Walnut Creek, California, United States
NCT03099096
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Diego, California, United States
Completed
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
NCT01691859
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site New Haven, Connecticut, United States